Notably, in vitro results show that antigen-stimulated proliferation of CD4+ and CD8+ T lymphocytes of MS patients is reduced when CD19+ B cells are removed from cultures, possibly as an effect of the diminished secretion of LT and TNFα, cytokines supporting T lymphocytes proliferation, by B cells14. The gene discussed is CD19; the disease is myeloid sarcoma.